The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Priorities for cancer research in low- and middle-income countries: a global perspective
Open accessAbstract
Cancer research currently is heavily skewed toward high-income countries (HICs), with little research conducted in, and relevant to, the problems of low- and middle-income countries (LMICs). This regional discordance in cancer knowledge generation and application needs to be rebalanced. Several gaps in the research enterprise of LMICs need to be addressed to promote regionally relevant research, and radical rethinking is needed to address the burning issues in cancer care in these regions. We identified five top priorities in cancer research in LMICs based on current and projected needs: reducing the burden of patients with advanced disease; improving access and affordability, and outcomes of cancer treatment; value-based care and health economics; quality improvement and implementation research; and leveraging technology to improve cancer control. LMICs have an excellent opportunity to address important questions in cancer research that could impact cancer control globally. Success will require collaboration and commitment from governments, policy makers, funding agencies, health care organizations and leaders, researchers and the public. Radical rethinking is needed to address the burning issues in cancer care in low- and middle-income countries. In this Perspective, the authors outline the main challenges and top priorities for cancer research now and into the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Successes and Failures in the Implementation of Evidence-Based Guidelines for Clinical Practice
Grol, R. (2001) · Medical Care · doi:10.1097/00005650-200108002-00003 · Cited by 1,233
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220 · cited 2×
“Furthermore, many methods used in health economic analyses fail to account for the different economic contexts, health impacts, individual and societal preferences or values of LMICs 69,70 .”
Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070
Soerjomataram, I., & Bray, F. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00514-z · Cited by 1,012
[Global health 2035: a world converging within a generation].
Jamison, D. T. T., Summers, L. H., Alleyne, G. A. O., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., EVANS, D. B., Feachem, R. G., Frenk, J. M., et al. (2015) · PubMed · Cited by 940
How Good Is the Quality of Health Care in the United States?
Schuster, M. A., McGlynn, E. A., & Brook, R. H. (1998) · The Milbank Quarterly · doi:10.1111/1468-0009.00105 · Cited by 908
Bray, F., Ferlay, J., Laversanne, M., Brewster, D. H., Gombe Mbalawa, C., Kohler, B., Piñeros, M., Steliarova‐Foucher, E., Swaminathan, R., Antoni, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29670 · Cited by 643
Badwe, R., Hawaldar, R., Nair, N., Kaushik, R., Parmar, V., Siddique, S., Budrukkar, A., Mittra, I., & Gupta, S. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00135-7 · Cited by 592
Self-citationChallenges to effective cancer control in China, India, and Russia
Goss, P. E., Strasser-Weippl, K., Lee-Bychkovsky, B. L., Fan, L., Li, J., Chavarri-Guerra, Y., Liedke, P. E. R., Pramesh, C. S., Badovinac-Crnjevic, T., Sheikine, Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70029-4 · Cited by 496
Self-citationDuncan, K., Abudu, R., Cira, M. K., & Pyle, D. H. M. (2019) · Journal of Global Oncology · doi:10.1200/jgo.19.11000 · Cited by 480
Cited by
Wang, S., Zheng, R., Li, J., Zeng, H., Li, L., Chen, R., Sun, K., Han, B., Bray, F., Wei, W., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00366-7 · Cited by 282
Harnessing the Power of Clinical Decision Support Systems: Challenges and Opportunities
Chen, Z., Liang, N., Zhang, H., Li, H., Yang, Y., Zong, X., Chen, Y., Wang, Y., & Shi, N. (2023) · Open Heart · doi:10.1136/openhrt-2023-002432 · Cited by 244
Salako, O., Enyi, A., Miesfeldt, S., Kabukye, J. K., Ngoma, M., Namisango, E., LeBaron, V., Sisimayi, C., Ebenso, B., Lorenz, K. A., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20247190 · Cited by 15
Dau, H., Kassam, F., Payne, B. A., Miller, H., & Ogilvie, G. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000609 · Cited by 2
Metadata
- Authors
- Pramesh, C. S., Badwe, R. A., Bhoo-Pathy, N., Booth, C. M., Chinnaswamy, G., Dare, A. J., de Andrade, V. P., Hunter, D. J., Gopal, S., Gospodarowicz, M., Gunasekera, S., Ilbawi, A., Kapambwe, S., Kingham, P., Kutluk, T., Lamichhane, N., Mutebi, M., Orem, J., Parham, G., Ranganathan, P., Sengar, M., Sullivan, R., Swaminathan, S., Tannock, I. F., Tomar, V., Vanderpuye, V., Varghese, C., & Weiderpass, E.
- Venue
- Nature Medicine
- Published
- 2022-04
- Volume
- 28
- Issue
- 4
- Pages
- 649-657
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4224288650
- Cited by
- 434
- References
- 69
- FWCI
- 45.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Priorities for cancer research in low- and middle-income countries: a global perspective. https://app.cochat.ai/papers/10.1038/s41591-022-01738-x
- The paper
- Pramesh, C. S., Badwe, R. A., Bhoo-Pathy, N., Booth, C. M., Chinnaswamy, G., Dare, A. J., de Andrade, V. P., Hunter, D. J., Gopal, S., Gospodarowicz, M., Gunasekera, S., Ilbawi, A., Kapambwe, S., Kingham, P., Kutluk, T., Lamichhane, N., Mutebi, M., Orem, J., Parham, G., . . . Weiderpass, E. (2022). Priorities for cancer research in low- and middle-income countries: a global perspective. Nature Medicine. https://doi.org/10.1038/s41591-022-01738-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
